Supernus Pharmaceuticals Inc (SUPN)
30.09
-0.51
(-1.67%)
USD |
NASDAQ |
Apr 30, 16:00
30.12
+0.03
(+0.10%)
Pre-Market: 20:00
Supernus Pharmaceuticals Cash from Operations (Quarterly): 44.96M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.96M |
| September 30, 2023 | 35.88M |
| June 30, 2023 | -18.87M |
| March 31, 2023 | 49.13M |
| December 31, 2022 | 27.56M |
| September 30, 2022 | 13.84M |
| June 30, 2022 | 71.12M |
| March 31, 2022 | 4.302M |
| December 31, 2021 | 48.76M |
| September 30, 2021 | -4.11M |
| June 30, 2021 | 46.27M |
| March 31, 2021 | 36.20M |
| December 31, 2020 | 31.93M |
| September 30, 2020 | 5.599M |
| June 30, 2020 | 91.95M |
| March 31, 2020 | 8.916M |
| December 31, 2019 | 43.79M |
| September 30, 2019 | 37.66M |
| June 30, 2019 | 28.69M |
| March 31, 2019 | 32.99M |
| December 31, 2018 | 32.85M |
| September 30, 2018 | 62.45M |
| June 30, 2018 | 6.556M |
| March 31, 2018 | 27.13M |
| December 31, 2017 | 36.34M |
| Date | Value |
|---|---|
| September 30, 2017 | 39.00M |
| June 30, 2017 | 25.94M |
| March 31, 2017 | 13.36M |
| December 31, 2016 | 24.94M |
| September 30, 2016 | 28.24M |
| June 30, 2016 | 16.78M |
| March 31, 2016 | -3.142M |
| December 31, 2015 | 19.93M |
| September 30, 2015 | 1.885M |
| June 30, 2015 | 12.98M |
| March 31, 2015 | -0.265M |
| December 31, 2014 | 6.263M |
| September 30, 2014 | -4.714M |
| June 30, 2014 | -6.94M |
| March 31, 2014 | -19.10M |
| December 31, 2013 | -9.421M |
| September 30, 2013 | -15.55M |
| June 30, 2013 | -15.76M |
| March 31, 2013 | -17.22M |
| December 31, 2012 | -16.14M |
| September 30, 2012 | -11.30M |
| June 30, 2012 | -9.689M |
| March 31, 2012 | -10.07M |
| December 31, 2011 | -8.258M |
| September 30, 2011 | -9.102M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.87M
Minimum
Jun 2023
91.95M
Maximum
Jun 2020
31.77M
Average
35.88M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| Dynavax Technologies Corp | 13.77M |
| Ligand Pharmaceuticals Inc | 8.065M |
| Pacira BioSciences Inc | 47.58M |
| Esperion Therapeutics Inc | -37.06M |
| Collegium Pharmaceutical Inc | 73.34M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -65.98M |
| Cash from Financing (Quarterly) | 1.092M |
| Free Cash Flow | 110.53M |
| Free Cash Flow Per Share (Quarterly) | 0.8136 |
| Free Cash Flow to Equity (Quarterly) | 44.99M |
| Free Cash Flow to Firm (Quarterly) | 44.99M |
| Free Cash Flow Yield | 6.48% |